A retrospective pilot study of bivalirudin versus unfractionated heparin as an adjunct to transcatheter aortic valve interventions.

Trial Profile

A retrospective pilot study of bivalirudin versus unfractionated heparin as an adjunct to transcatheter aortic valve interventions.

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Nov 2011

At a glance

  • Drugs Bivalirudin; Heparin
  • Indications Thrombosis
  • Focus Adverse reactions
  • Acronyms BRAVO
  • Most Recent Events

    • 14 Nov 2011 New trial record
    • 08 Nov 2011 Results were presented at the 2011 Transcatheter Cardiovascular Therapeutics conference, according to a media release from The Medicines Company. Results were also reported in the media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top